Get the Stockscreener App
6.985
3.39%
-0.245
Lifecore Biomedical Inc stock is traded at $6.985, with a volume of 163.27K.
It is down -3.39% in the last 24 hours and down -7.97% over the past month.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
See More
Previous Close:
$7.23
Open:
$7.29
24h Volume:
163.27K
Relative Volume:
1.03
Market Cap:
$261.52M
Revenue:
$128.45M
Net Income/Loss:
$6.54M
P/E Ratio:
139.70
EPS:
0.05
Net Cash Flow:
$-8.79M
1W Performance:
-7.61%
1M Performance:
-7.97%
6M Performance:
-8.45%
1Y Performance:
+22.12%
1-Day Range:
$6.845
$7.41
1-Week Range:
$6.845
$8.1799
52-Week Range:
$4.76
$8.9799
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Name
Lifecore Biomedical Inc
Sector
Phone
(952) 368-4300
Address
3515 LYMAN BOULEVARD, CHASKA
Compare LFCR vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
6.98 | 270.88M | 128.45M | 6.54M | -8.79M | 0.05 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.36 | 57.75B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.16 | 56.70B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.19 | 49.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.97 | 39.96B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
478.24 | 20.49B | 3.13B | 1.27B | 1.12B | 26.39 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-21-25 | Initiated | William Blair | Outperform |
| Sep-05-24 | Initiated | Craig Hallum | Buy |
| Aug-28-24 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-20-23 | Downgrade | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Stock (LFCR) Latest News
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation - ACCESS Newswire
(LFCR) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out - ACCESS Newswire
Aug Reactions: What drives Lifecore Biomedical Incs stock priceMarket Volume Report & High Return Stock Watch Alerts - baoquankhu1.vn
2026-02-01 | Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Shareholders to Inquire about Securities Investigation | NDAQ:LFCR | Press Release - Stockhouse
Can Lifecore Biomedical Inc continue delivering strong returnsJuly 2025 Selloffs & Smart Allocation Stock Tips - baoquankhu1.vn
Market Recap: Is OPTT vulnerable to short sellersRecession Risk & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Portfolio Shifts: Is Lifecore Biomedical Inc a strong candidate for buy and holdIndex Update & Risk Controlled Swing Alerts - baoquankhu1.vn
Notice to Long-Term Shareholders of Lifecore Biomedical, - GlobeNewswire
HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
2026-01-29 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect | NDAQ:LFCR | Press Release - Stockhouse
Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: - GlobeNewswire
Is Lifecore Biomedical Inc. a defensive stockTrade Entry Summary & Free Community Supported Trade Ideas - mfd.ru
(LFCR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - accessnewswire.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - accessnewswire.com
2026-01-25 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
Notice to Long-Term Shareholders of Ibatta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf - GlobeNewswire
Aug PreEarnings: Is Lifecore Biomedical Inc trading at a discountJuly 2025 Decliners & Low Risk Entry Point Tips - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Notice to Long-Term Shareholders of CoreWeave, Inc. - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2026-01-20 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) Subdued P/S Might Signal An Opportunity - simplywall.st
Attention Long-Term Shareholders of Ibotta, Inc. (NYSE: - GlobeNewswire
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - marketscreener.com
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com
2026-01-18 | Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
(LFCR) Risk Channels and Responsive Allocation - Stock Traders Daily
Lifecore Investors Ink $3.8M Deal In Accounting Controls Suit - Law360
Lifecore Biomedical Adopts New Performance-Based Incentive Bonus Plan - TipRanks
What Contributes to Lifecore Biomedical’s (LFCR) Distinct Competitive Advantage? - Insider Monkey
Attention Long-Term Shareholders of Integer Holdings Corp, - GlobeNewswire
Townhall - FinancialContent
Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
Whittier Daily News - FinancialContent
Lifecore Biomedical: Wins Should Blow Previous 'New Business' Estimates Out Of The Water (undefined:LFCR) - Seeking Alpha
Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Settles - TMX Newsfile
Important Notice to Long-Term Shareholders of Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Clai - GlobeNewswire
Insider Trends: Why Lifecore Biomedical Inc stock could rally in 20252025 Risk Factors & Stepwise Trade Signal Guides - Bộ Nội Vụ
Aug Selloffs: Why Lifecore Biomedical Inc. stock attracts high net worth investors2025 Market Sentiment & Stock Market Timing Techniques - Улправда
Pullback Watch: Can Lifecore Biomedical Inc. (LDE) stock deliver strong annual returnsJuly 2025 Closing Moves & Technical Buy Zone Confirmations - ulpravda.ru
Important Notice to Long-Term Shareholders of Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Beh - GlobeNewswire
About Us - FinancialContent
Why Lifecore Biomedical Inc. stock attracts high net worth investorsDividend Hike & Low Volatility Stock Recommendations - Улправда
Is Lifecore Biomedical Inc. stock dividend yield sustainableWeekly Market Report & Daily Stock Trend Watchlist - Улправда
Why Lifecore Biomedical Inc. stock could rally in 2025July 2025 Volume & Risk Adjusted Buy and Sell Alerts - Улправда
How institutional buying supports Lifecore Biomedical Inc. stock2025 Support & Resistance & Real-Time Chart Breakout Alerts - Улправда
Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Reaches Settlement - TMX Newsfile
Why Lifecore Biomedical Inc. stock is a must watch in 2025Market Activity Recap & Weekly Setup with ROI Potential - Улправда
Lifecore Biomedical Inc Stock (LFCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.56%
10.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):